Published in Hepatitis Weekly, October 23rd, 2006
"Alcohol use and HIV infection are both associated with accelerated progression of HCV disease and reduced response rates to interferon therapy. In this study, we assessed the prevalence of barriers to interferon treatment in a population of HIV/HCV-coinfected patients with current or past alcohol problems and the extent to which they received treatment to address the barriers," wrote D. Nunes and colleagues, Boston Medical Center.
"This is a cross-sectional, descriptive analysis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.